Rationale and study protocol for a randomized controlled feeding study to determine the structural- and functional-level effects of diet-specific interventions on the gut microbiota of non-Hispanic black and white adults.

Autor: Carson TL; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, United States of America. Electronic address: tiffany.carson@moffitt.org., Buro AW; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, United States of America., Miller D; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, United States of America., Peña A; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, United States of America., Ard JD; Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, NC, United States of America., Lampe JW; Public Health Science Division, Fred Hutchinson Cancer Center, Seattle, WA, United States of America., Yi N; Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, United States of America., Lefkowitz E; Center for Clinical and Translational Sciences, University of Alabama at Birmingham, Birmingham, AL, United States of America; Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, United States of America., William VP; Center for Clinical and Translational Sciences, University of Alabama at Birmingham, Birmingham, AL, United States of America., Morrow C; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, United States of America., Wilson L; Department of Pharmacology and Toxicology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States of America; Targeted Metabolomics and Proteomics Laboratory, University of Alabama at Birmingham, Birmingham, AL, United States of America., Barnes S; Department of Pharmacology and Toxicology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States of America; Targeted Metabolomics and Proteomics Laboratory, University of Alabama at Birmingham, Birmingham, AL, United States of America., Demark-Wahnefried W; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, United States of America.

Publikováno v: Contemporary clinical trials [Contemp Clin Trials] 2022 Dec; Vol. 123, pp. 106968. Date of Electronic Publication: 2022 Oct 18.